-
1دورية أكاديمية
المؤلفون: Rigby, Mark R, DiMeglio, Linda A, Rendell, Marc S, Felner, Eric I, Dostou, Jean M, Gitelman, Stephen E, Patel, Chetanbabu M, Griffin, Kurt J, Tsalikian, Eva, Gottlieb, Peter A, Greenbaum, Carla J, Sherry, Nicole A, Moore, Wayne V, Monzavi, Roshanak, Willi, Steven M, Raskin, Philip, Moran, Antoinette, Russell, William E, Pinckney, Ashley, Keyes-Elstein, Lynette, Howell, Michael, Aggarwal, Sudeepta, Lim, Noha, Phippard, Deborah, Nepom, Gerald T, McNamara, James, Ehlers, Mario R
المساهمون: Department of Pediatrics, IU School of Medicine
المصدر: PMC
مصطلحات موضوعية: Diabetes Mellitus, Type 1, blood, drug therapy, Drug Delivery Systems, methods, Immunologic Memory, drug effects, Recombinant Fusion Proteins, administration & dosage, T-Lymphocytes
وصف الملف: application/pdf
العلاقة: The lancet. Diabetes & endocrinology; Rigby, M. R., DiMeglio, L. A., Rendell, M. S., Felner, E. I., Dostou, J. M., Gitelman, S. E., … the T1DAL Study Team. (2013). Targeting effector memory T cells with alefacept in new onset type 1 diabetes: 12 month results from the T1DAL study. The Lancet. Diabetes & Endocrinology, 1(4), 284–294. http://doi.org/10.1016/S2213-8587Test(13)70111-6; https://hdl.handle.net/1805/8663Test
الإتاحة: https://hdl.handle.net/1805/8663Test
-
2كتاب
المؤلفون: Bucher, Nancy L.R., McGowan, Joan A., Russell, William E.
المصدر: Nerve, Organ, and Tissue Regeneration ; page 455-469